Kanamycin
Kanamycin A is an orally available aminoglycoside antibiotic that inhibits bacterial protein synthesis by targeting ribosomal RNA. It is widely used in research applications, including in vitro studies against Mycobacterium tuberculosis and in vivo models of bacterial pneumonia.
Product Specifications
CAS Number
8063-07-8
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.22% (May vary between batches)
Solubility
H2O:100 mg/mL (206.4 mM) ; DMSO:< 1 mg/mL (insoluble)
Smiles
N[C@@H]1[C@@H] (O[C@@H]2[C@H] (O) [C@@H] (O) [C@H] (O) [C@@H] (CN) O2) [C@H] (O) [C@@H] (O[C@@H]3[C@H] (O) [C@@H] (N) [C@H] (O) [C@@H] (CO) O3) [C@H] (N) C1
Molecular Formula
C18H36N4O11
Molecular Weight
484.50
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3010140-01 20 µg
Recombinant Human UDP-glucuronosyltransferase 2A2 (UD2A2), partial
Sign In for Pricing
View Details 
orb3010140-02 100 µg
Recombinant Human UDP-glucuronosyltransferase 2A2 (UD2A2), partial
Sign In for Pricing
View Details orb3010140-03 1 mg
Recombinant Human UDP-glucuronosyltransferase 2A2 (UD2A2), partial
Sign In for Pricing
View Details MBS1883324-01 0.01 mg
Human 5HT1D-Strep full length protein-synthetic nanodisc
Sign In for Pricing
View Details MBS1883324-02 0.05 mg
Human 5HT1D-Strep full length protein-synthetic nanodisc
Sign In for Pricing
View Details